Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Companyverified

HZNP

Price:

$116.3

Market Cap:

$0

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamm...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2011-07-28

Stock Exchange

NASDAQ

Ticker

HZNP

The PE Ratio as of June 2024 (TTM) for Horizon Therapeutics Public Limited Company (HZNP) is 61.86

According to Horizon Therapeutics Public Limited Company’s latest financial reports and current stock price. The company's current PE Ratio is 61.86. This represents a change of 3.05% compared to the average of 60.03 of the last 4 quarters.

Horizon Therapeutics Public Limited Company (HZNP) Historical PE Ratio (quarterly & annually)

How has HZNP PE Ratio performed in the past?

The mean historical PE Ratio of Horizon Therapeutics Public Limited Company over the last ten years is 15.79. The current 61.86 PE Ratio has changed 39.08% with respect to the historical average. Over the past ten years (40 quarters), HZNP's PE Ratio was at its highest in in the September 2015 quarter at 240.47. The PE Ratio was at its lowest in in the June 2019 quarter at -225.78.

Quarterly (TTM)
Annual

Average

15.79

Median

4.85

Minimum

-43.76

Maximum

81.56

Horizon Therapeutics Public Limited Company (HZNP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Horizon Therapeutics Public Limited Company PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 654.37%

Maximum Annual PE Ratio = 81.56

Minimum Annual Increase = -2091.52%

Minimum Annual PE Ratio = -43.76

Quarterly (TTM)
Annual
YearPE RatioChange
202250.009.95%
202145.4712.54%
202040.41211.65%
201912.96-129.62%
2018-43.76654.37%
2017-5.80-62.78%
2016-15.59-119.11%
201581.56-2091.52%
2014-4.1025.80%
2013-3.26215.56%

Horizon Therapeutics Public Limited Company (HZNP) Average PE Ratio

How has HZNP PE Ratio performed in the past?

The current PE Ratio of Horizon Therapeutics Public Limited Company (HZNP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

45.29

5-year avg

21.02

10-year avg

15.79

Horizon Therapeutics Public Limited Company (HZNP) PE Ratio vs. Peers

How is HZNP’s PE Ratio compared to its peers?

Horizon Therapeutics Public Limited Company’s PE Ratio is greater than Bristol-Myers Squibb Company (-13.56), greater than AbbVie Inc. (49.76), less than Merck & Co., Inc. (142.23), less than Gilead Sciences, Inc. (167.62), greater than Johnson & Johnson (9.11), greater than Amgen Inc. (42.54), less than Eli Lilly and Company (128.91), greater than AstraZeneca PLC (38.95), greater than Sanofi (15.27), greater than Novartis AG (14.17), greater than GSK plc (29.08), greater than Roche Holding AG (1.43),

CompanyPE RatioMarket cap
-13.56$83.52B
49.76$297.71B
142.23$327.95B
167.62$81.06B
9.11$350.27B
42.54$160.19B
128.91$834.88B
38.95$246.77B
15.27$115.89B
14.17$206.84B
29.08$82.89B
1.43$223.99B

Build a custom stock screener for Horizon Therapeutics Public Limited Company (HZNP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Horizon Therapeutics Public Limited Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Horizon Therapeutics Public Limited Company (HZNP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Horizon Therapeutics Public Limited Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Horizon Therapeutics Public Limited Company's PE Ratio?

How is the PE Ratio calculated for Horizon Therapeutics Public Limited Company (HZNP)?

What is the highest PE Ratio for Horizon Therapeutics Public Limited Company (HZNP)?

What is the 3-year average PE Ratio for Horizon Therapeutics Public Limited Company (HZNP)?

What is the 5-year average PE Ratio for Horizon Therapeutics Public Limited Company (HZNP)?

How does the current PE Ratio for Horizon Therapeutics Public Limited Company (HZNP) compare to its historical average?